ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,638Medicare Part D Prescriptions Filled, Including Refills

Rank: 429 out of 1121

$546K Total Retail Price of All Prescriptions

Rank: 353 out of 1121

351 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
30% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 351 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

14% of this provider’s 351 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

1% of this provider’s 6,735 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
SIMVASTATIN 384 308 1 1
HYDROCODONE-ACETAMINOPHEN 309 211 S3 2 3
AMLODIPINE BESYLATE 255 226 3 5
LEVOTHYROXINE SODIUM 222 169 4 2
POTASSIUM CHLORIDE 168 159 5 12
OMEPRAZOLE 158 123 6 6
HYDROCHLOROTHIAZIDE 153 121 7 10
LISINOPRIL 153 112 7 4
METOPROLOL TARTRATE 150 118 9 9
TRIAMTERENE-HCTZ 147 132 10 38
FUROSEMIDE 144 126 11 7
WARFARIN SODIUM 138 105 12 11
LOVASTATIN 121 109 13 26
PRAVASTATIN SODIUM 114 95 14 14
ATORVASTATIN CALCIUM 105 101 15 15
METOPROLOL SUCCINATE 105 90 15 23
LOSARTAN POTASSIUM 102 86 17 17
CITALOPRAM HBR 100 75 18 18
METFORMIN HCL ER 96 79 19 47
NEXIUM 96 54 19 24
CYMBALTA 95 66 21 50
RANITIDINE HCL 91 84 22 33
ZOLPIDEM TARTRATE 90 55 23 19
BENAZEPRIL HCL 89 72 24 41
TRAMADOL HCL 87 45 25 25
ATENOLOL 86 84 26 16
CLONIDINE HCL 85 68 27 39
FENOFIBRATE 81 62 28 71
PANTOPRAZOLE SODIUM 77 69 29 29
NAMENDA 75 75 30 53
CLOPIDOGREL 75 61 30 27
GLIMEPIRIDE 74 61 32 34
ENALAPRIL MALEATE 73 67 33 73
GABAPENTIN 72 36 34 13
ALLOPURINOL 69 61 35 30
PREDNISONE 69 68 35 43
METFORMIN HCL 68 50 37 8
SPIRIVA 67 45 38 49
HYDRALAZINE HCL 61 46 39 66
TRAZODONE HCL 59 33 40 40
PROAIR HFA 57 16 41 48
MONTELUKAST SODIUM 54 48 42 144
ZETIA 53 48 43 80
QUINAPRIL HCL 52 39 44 127
SINGULAIR 51 46 45 78
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 30, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.